426 results about "Back pain" patented technology

Devices and methods for treating a damaged intervertebral disc to reduce or eliminate associated back pain. Dynamic bias devices and reinforcement devices are disclosed, which may be used individually or in combination, to eliminate nerve impingement associated with the damaged disc, and / or to reinforce the damaged disc, while permitting relative movement of the vertebrae adjacent the damaged disc.

Systems, apparatus, and methods for treating spinal tissue and other body structures in open and endoscopic spine surgery to relieve symptoms, such as neck or back pain. In particular, the present invention provides methods for the controlled heating of various tissues in or around the vertebral column, including various interspinous tissues, such that spinal ligaments and cartilage surrounding the vertebrae and the facet joints are shrunk or tightened to stabilize the vertebral column of a patient. Thermal energy is applied to the target tissue in a subablation mode of an electrosurgical system to cause shrinkage of the tissue, thereby stiffening the interspinous tissue and stabilizing the vertebral column. In an exemplary embodiment, a high frequency RF voltage can be applied between one or more active electrode(s) and one or more return electrode(s) to heat a target interspinous tissue to within a temperature range at which irreversible shrinkage of the tissue occurs.

The subject disclosure are directed to systems, apparatuses, devices and methods for vertebral and spinal correction. In some embodiments, an expansible implant is provided which may be inserted between two vertebrae, for instance, for maintenance and / or restoration of the distance / space between vertebrae. The implant may include first and second opposed plates that are intended to move away from one another, and which engage portions of vertebrae via a recess provided for on a bearing surface of the plates. The implant may additionally include at least first and second opposed end members, where at least one of the end members includes an aperture configured for receiving at least a portion of a retaining element adapted for retaining the implant in an expanded configuration once the implant is expanded. Methods of treatment and methods of use of such implants for the alleviation of back pain (for example) are also provided herein.

Apparatus and methods for treating back pain are provided, in which an implantable stimulator is configured to communicate with an external control system, the implantable stimulator providing a neuromuscular electrical stimulation therapy designed to cause muscle contraction to rehabilitate the muscle, restore neural drive and restore spinal stability; the implantable stimulator further including one or more of a number of additional therapeutic modalities, including a module that provides analgesic stimulation; a module that monitors muscle performance and adjusts the muscle stimulation regime; and / or a module that provides longer term pain relief by selectively and repeatedly ablating nerve fibers. In an alternative embodiment, a standalone implantable RF ablation system is described.

The subject disclosure is directed to systems, apparatuses, devices and methods for vertebral and spinal correction. In some embodiments, an expandable implant is provided which may be inserted inside the vertebral body and / or between two vertebrae, for instance, for maintenance and / or restoration of a space therein or there between. In certain embodiments, the implant includes a mechanical resistance that prevents the expandable implant from contracting once it has been expanded. Methods of treatment and methods of use of such implants for the alleviation of back pain (for example) are also provided herein.

A method for treating pain, particularly non-inflammatory musculoskeletal pain such as fibromyalgia, myofascial pain or back pain, in a subject comprises administering to the subject a substituted 2-aminotetralin compound as defined herein, illustratively rotigotine.

A system for treating pain uses spinal cord stimulation and peripheral subcutaneous field stimulation separately or in combination. The system includes an implantable device that is configured to deliver several electrical signals. Several electrical leads are connected to the implantable device. The electrical leads are implanted in the patient such that an electrical signal induces a current to flow between a subcutaneous lumbar region of the patient and a spinal cord region of the patient. The system can also include electrical leads that are implanted in the patient such that an electrical signal induces a current to flow across a lumbar region of the patient. A method for treating leg and back pain is also disclosed.

Devices and methods for treating a damaged intervertebral disc to reduce or eliminate associated back pain. The present invention provides disc reinforcement therapy (DRT) which involves implanting one or more reinforcement members in and preferably around the annulus of the disc. The reinforcement members may be used to stabilize the annulus and / or compresses a portion of the annulus so as to reduce a bulge and / or close a fissure. The implantable devices and associated delivery tools may incorporate heating capabilities to thermally treat the annular tissue. Alternatively or in combination, other devices may be specifically employed for such thermal treatment.

The invention encompasses devices and methods for treating one or more damaged, diseased, or traumatized intervertebral discs to reduce or eliminate associated back pain. Specifically, the invention encompasses intervertebral nucleus and annulus implants that are resistant to migration in and / or expulsion from an intervertebral disc space. The invention further encompasses kits including the implantable devices of the invention and associated delivery tools to treat annular and nuclear tissue.

The present invention relates to devices and methods for treating one or more damaged, diseased, or traumatized portions of the spine, including intervertebral discs, to reduce or eliminate associated back pain. The present invention relates to an expandable interbody spacer.

The intervertebral disc is avascular. With aging, endplates become occluded by calcified layers, and diffusion of nutrients and oxygen into the disc diminishes. The disc degenerates, and pain ensues. Conduits are delivered and deployed into the intervertebral disc to re-establish the exchange of nutrients and waste between the disc and bodily circulation to stop or reverse disc degeneration and relieve pain. The intervertebral disc installed with semi-permeable conduits may be used as an immuno-isolated capsule to encapsulate donor cells capable of biosynthesizing therapeutic molecules. The semi-permeable conduits establish the exchange of nutrients and therapeutic molecules between disc and bodily circulation to treat a disease without using immuno-suppressive drugs.

Systems and methods for enhanced implantation of an electrode lead for neuromuscular electrical stimulation of tissue associated with control of the lumbar spine for treatment of back pain, in a midline-to-lateral manner are provided. The implanted lead may be secured within the patient and used to restore muscle function of local segmental muscles associated with the lumbar spine stabilization system without disruption of the electrode lead post-implantation due to anatomical structures.

A once-a-day oral milnacipran modified release formulation has been developed. The formulation comprises an extended release dosage unit (optionally containing the immediate release portion) coated with delayed release coating. The milnacipran composition, when administered orally, first passes through the stomach releasing from zero to less than 10% of the total milnacipran dose and then enters the intestines where drug is released slowly over an extended period of time. The release profile is characterized by a 0.05-4 hours lag time period during which less than 10% of the total milnacipran dose is released followed by a slow or extended release of the remaining drug over a defined period of time. The composition provides in vivo drug plasma levels characterized by Tmax at 4-10 hours and an approximately linear drop-off thereafter and Cmax below 3000 ng / ml, preferably below 2000 ng / ml, and most preferably below 1000 ng / ml. The composition allows milnacipran to be delivered over approximately 24 hours, when administered to a patient in need, resulting in diminished incidence or decreased intensity of common milnacipran side effects such as sleep disturbance, nausea, vomiting, headache, tremulousness, anxiety, panic attacks, palpitations, urinary retention, orthostatic hypotension, diaphoresis, chest pain, rash, weight gain, back pain, constipation, vertigo, increased sweating, agitation, hot flushes, tremors, fatigue, somnolence, dyspepsia, dysoria, nervousness, dry mouth, abdominal pain, irritability, and insomnia.

The intervertebral disc is avascular. With aging, nutrients and oxygen transporting through the endplates diminish. The disc degenerates, and pain ensues. Conduits are delivered through a pedicle or vertebral body into the intervertebral disc to re-establish the exchange of nutrients and waste between the disc and bodily circulation to slow, stop or reverse disc degeneration and relieve pain. Endplate plugs may be deployed to seal gaps between the conduits and the endplates to prevent immune responses to the nucleus pulposus and to preserve the hydrostatic pressure within the disc.

Devices and methods for treating a damaged intervertebral disc to reduce or eliminate associated back pain. The present invention provides disc reinforcement therapy (DRT) which involves implanting one or more reinforcement members in and preferably around the annulus of the disc. The reinforcement members may be used to stabilize the annulus and / or compresses a portion of the annulus so as to reduce a bulge and / or close a fissure. The implantable devices and associated delivery tools may incorporate heating capabilities to thermally treat the annular tissue. Alternatively or in combination, other devices may be specifically employed for such thermal treatment.

The intervertebral disc is avascular. Nutrients and waste are diffused through adjacent vertebral bodies into the disc. As we age, calcified layers form between the disc and vertebral bodies, blocking diffusion of nutrients, oxygen and pH buffer in blood. Under anaerobic conditions, lactic acid is produced, irritating nerve endings and causing nonspecific pain. In addition, the disc begins to starve and flatten. The weight shifts abnormally from disc to the facet joints causing strain and back pain.Shunt coils are formed and spiraled over the distal shaft of a twistable needle, then deployed into the nucleus of a degenerated disc by a sliding sleeve. The coils serve as an internal shunt, drawing nutrients, oxygen and buffering solute from the superior and inferior diffusion zones to neutralize lactic acid in the mid layer of the degenerated disc. The coils also serve as a bulking agent within the repaired disc to sustain compression and reduce facet loading and segmental instability. The end strands of the shunt coils can also extend from the disc to draw blood plasma from muscle or bodily circulation to expedite neutralization of lactic acid and rebuild disc matrix for pain relief and disc regeneration.

Devices and methods for treating a damaged intervertebral disc to reduce or eliminate associated back pain. Dynamic bias devices and reinforcement devices are disclosed, which may be used individually or in combination, to eliminate nerve impingement associated with the damaged disc, and / or to reinforce the damaged disc, while permitting relative movement of the vertebrae adjacent the damaged disc.

A system is described for long-term controlled release delivery of a drug or a therapeutic agent. According to the invention, one or more drugs or therapeutic agents contained in microspheres are mixed with a temperature sensitive hydrogel which is then introduced directly to the desired situs of the drug or therapeutic agent. The temperature sensitive hydrogel may also contain a drug or a therapeutic agent, for example, a pain relieving drug, for a short-term controlled release. The temperature sensitive hydrogel is in liquid state at room temperature, but upon injection, shortly becomes gelatinous. This system is particularly suitable for treatment of diseases, disorders, or conditions, for example, tumors, discogenic back pain, or arthritis, warranting localized administration of a drug or a therapeutic agent. In addition, the specification provides a method for production of a drug—or therapeutic agent-containing microspheres.

The subject disclosure is directed to systems, apparatuses, devices and methods for vertebral and spinal correction. In some embodiments, an expandable implant is provided which may be inserted inside the vertebral body and / or between two vertebrae, for instance, for maintenance and / or restoration of a space therein or there between. In certain embodiments, the implant includes a mechanical resistance that prevents the expandable implant from contracting once it has been expanded. Methods of treatment and methods of use of such implants for the alleviation of back pain (for example) are also provided herein.

The present invention reduces pain and improves function long-term in persons with back pain using electrical stimulation in the back. This approach involves an electrical stimulation device including at least one electrode adapted for insertion within an animal body with back pain and at least one pulse generator operatively coupled with the at least one electrode, wherein the pulse generator delivers electrical stimulation activating at least one muscle in a back of the animal body for pain relief.

Various devices and methods for accessing and preparing treatment sites within the intervertebral disc space for subsequent negligible-incision surgical (NIS) or percutaneous procedures to treat disc degeneration and disc related back pain are disclosed. Also disclosed is a method for performing a percutaneous spine procedure including preparing a treatment site within the intervertebral disc space for subsequent delivery of a biomaterial to treat disc degeneration and disc related back pain.

An ergonomic work station for computer components or for other purposes that is especially adapted for use by an individual having decreased mobility due to back pain or other conditions. The work station includes a base that extends beneath a chair or bed. A support arm has counter weight on a first side of a pivotal mount and a work table on a second side of the pivotal mount. The support arm may be pivoted to place the table in a work position in front of a user or in vertical position to permit unobstructed egress from or ingress to the chair or bed. The counter weight allows for the support arm to be easily pivoted from the work position to the vertical position by application of only very light pressure.

The intervertebral disc is avascular. With aging, endplates become occluded by calcified layers, and diffusion of nutrients and oxygen into the disc diminishes. The disc degenerates, and pain ensues. Conduits are delivered and deployed into the intervertebral disc to reestablish the exchange of nutrients and waste between the disc and bodily circulation to stop or reverse disc degeneration and relieve pain. The intervertebral disc installed with semi-permeable conduits may be used as an immuno-isolated capsule to encapsulate donor cells capable of biosynthesizing therapeutic molecules. The semi-permeable conduits establish the exchange of nutrients and therapeutic molecules between disc and bodily circulation to treat a disease without using immunosuppressive drugs.

A method for treating back pain by stabilizing the sacroiliac joint. The method includes fusing a sacrum bone to an ilium bone or otherwise mechanically immobilizing the sacroiliac joint by inserting at least two implants into voids formed within or between the articular surfaces of each sacroiliac joint of a patient without substantially distracting the joint. The voids are arranged within each joint at either a converging orientation or a diverging orientation. A kit containing the implants and tools required to insert the implants into the joint are also described.

Methods and systems for modulating intraosseous nerves (e.g., nerves within bone) are provided. For example, the methods and systems described herein may be used to modulate (e.g., denervate, ablate) basivertebral nerves within vertebrae. The modulation of the basivertebral nerves may facilitate treatment of chronic back pain. The modulation may be performed by a neuromodulation device (e.g., an energy delivery device).

An article of clothing has a main body formed of high-tightness, main-body knitting fabric made of power net. The article of clothing includes front and back support pieces disposed around the waist and having no elasticity in a longitudinal direction thereof. The front support pieces are sewn to a front body at positions inside the left and right ilia of the abdominal pelvis. The back support pieces are sewn to a back body at left and right positions near the sacrum of the pelvis in central hip portions. Side waist pieces disposed between the front and back support pieces are formed by sewing high-tightness, net-like knitting fabric to the main-body knitting fabric at the top edge while leaving the bottom edge unsewn. The article of clothing has a pant-like shape with left and right leg parts that can be tightly fitted around the thighs.